Mounjaro and mood side effects: what the evidence actually shows

Step 1: Understand what Mounjaro's prescribing information actually says about mood

Mounjaro's licensed status covers weight management in adults alongside a reduced-calorie diet and increased physical activity. The drug's Summary of Product Characteristics (the official clinical document behind the medicine) lists mood-related effects including depressed mood and anxiety. These fall into the category of effects reported during trials and post-marketing surveillance, rather than the very common GI effects (nausea, diarrhoea, constipation) that affect the majority of users in the first weeks of treatment.

The NHS tirzepatide medicines page notes that mood changes and low mood can occur. They are not classed as common (affecting more than 1 in 100 people) in the trial population, but that doesn't make them unimportant, nor does it mean they won't be significant for the individual experiencing them. The honest picture is that the evidence base is still developing, and the reporting system exists precisely to build it. Mounjaro carries a Black Triangle (▼) designation from the MHRA, meaning additional monitoring is ongoing and any new safety signal (including mood) will be tracked.

If you're trying to make sense of the full range of Mounjaro side effects, mood is one piece of a broader picture that includes gastrointestinal, metabolic and systemic effects, and our dedicated page on tirzepatide side effects and mood goes deeper into what the evidence currently shows for this specific area.

Step 2: Recognise what might be driving the mood change, it isn't always the medicine directly

Several things happening simultaneously during Mounjaro treatment can affect how you feel emotionally, and disentangling them matters.

First, appetite suppression can be dramatic. Eating far less than usual (sometimes much less than the body needs for adequate nutrition) can lower mood, reduce energy and blunt concentration. Protein intake in particular tends to fall when appetite drops sharply; inadequate protein is associated with fatigue and emotional flatness. Second, weight loss at pace involves genuine physiological change: hormonal shifts, altered sleep patterns and metabolic adjustment can all have downstream effects on mood. Third, the psychological experience of changing your relationship with food is not trivial. Some people feel unexpectedly anxious or low when a coping mechanism around eating is removed, even when that change is objectively positive for their health.

None of this means the medicine itself is causing harm; it means the picture is layered. Our guide to managing Mounjaro side effects covers practical strategies for the adjustment period, including nutrition and pacing.

Separately, it's worth knowing that GLP-1 receptor activity has effects in the brain as well as the gut, research into how tirzepatide and similar medicines interact with mood-related pathways is active, and findings from it will inform future prescribing guidance. For now, the clinical advice is to monitor and report.

Step 3: Know exactly when to get medical help

Most mood changes that occur early in treatment are mild, transient and settle as the body adjusts. But some need prompt attention. Contact a doctor (or 111 if your GP is unavailable) if you experience:

• Persistent low mood lasting more than a few days that is not improving
• Thoughts of self-harm or suicide
• Severe anxiety, panic attacks, or a significant change in your normal mental state
• Mood changes accompanied by other new symptoms you didn't have before starting treatment

You should also know that the MHRA's January 2026 Drug Safety Update for GLP-1 medicines focused on acute pancreatitis (severe, persistent stomach pain radiating to the back is the symptom to watch for there) but that update reinforces a broader point: any symptom that feels serious should be reported and assessed, not managed in silence.

If you're experiencing low mood specifically, the detailed page on Mounjaro and low mood covers the evidence and practical steps in more depth. And if you want to report a suspected side effect, the MHRA Yellow Card scheme is open to patients as well as healthcare professionals, your report genuinely contributes to the ongoing safety picture for this medicine.

Step 4: Talk to your prescriber before changing anything

If mood side effects are bothering you, the right move is a conversation with your prescriber, not stopping the medicine unilaterally, not increasing activity or nutrition changes without guidance, and not simply waiting and hoping. A prescriber can assess whether what you're experiencing is likely related to the medicine, dose-dependent, or connected to something else entirely. They can advise on whether a dose adjustment, a pause, or simply closer monitoring makes sense for your situation.

At nume, our GPhC-registered prescribers review every patient's progress before each repeat is issued, mood and wellbeing are part of that clinical picture, not a separate conversation you have to push for. If you have questions about how tirzepatide might suit your circumstances, our free consultation is the place to start. You can also read more about how Mounjaro works and the broader context of tirzepatide's effects on mood before you do. Our clinical team is available to answer questions as part of the process, not just at prescription stage.